# Study Of Remission In Patients Treated For Generalized Anxiety Disorder

> **NCT01788553** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 750 (actual)

## Conditions studied

- Anxiety Disorders

## Interventions

- **OTHER:** remission prevalence of generalized anxiety disorder

## Key facts

- **NCT ID:** NCT01788553
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-03
- **Final completion:** 2007-03
- **Target enrollment:** 750 (ACTUAL)
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01788553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01788553, "Study Of Remission In Patients Treated For Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01788553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*